YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

Pfizer may merge off-patent drug business with Mylan

Posted online

Pfizer Inc. is considering a merger of its off-patent drug business with generic drugmaker Mylan, people familiar with the matter told The Wall Street Journal.

Under the proposal, Mylan shareholders would own more than 40% of the new entity and Pfizer shareholders would own the remainder.

Such a deal would create a global company that sells lower-priced pharmaceuticals.

Read more from The Wall Street Journal.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Open for Business: The Quilted Cow

A franchise store of a Branson West-based quilting business made its Queen City debut; Grateful Vase launched in Lebanon; and Branson entertainment venue The Social Birdy had its grand opening.

Most Read
SBJ.net Poll
Update cookies preferences